Universe Pharmaceuticals (NYSE:UPC) Shares Down 0.4% – What’s Next?

Universe Pharmaceuticals INC (NYSE:UPC)’s share price traded down 0.4% during mid-day trading on Friday . The stock traded as low as $0.62 and last traded at $0.64. 594,071 shares traded hands during mid-day trading, a decline of 7% from the average session volume of 635,835 shares. The stock had previously closed at $0.64.

Universe Pharmaceuticals Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 1.63. The business’s 50-day moving average is $1.86 and its 200-day moving average is $23.06.

Hedge Funds Weigh In On Universe Pharmaceuticals

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. MML Investors Services LLC acquired a new stake in shares of Universe Pharmaceuticals INC (NYSE:UPC) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned about 6.46% of Universe Pharmaceuticals at the end of the most recent quarter. Institutional investors and hedge funds own 0.18% of the company’s stock.

Universe Pharmaceuticals Company Profile

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.